Nov 02, 2020
Israel begins human trials for COVID-19 vaccine
This news has been received from: New York Post
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
Two volunteers in separate hospitals – one in Tel Aviv and another in Jerusalem – have started the trials. If the two, Segev Harel and Aner Ottolenghi, feel in good health in the next two days, another 80 people will join the first phase of the trial.
According to officials, each volunteer will get either a dose of the vaccine or a placebo and will be sent home, where they will be monitored for three weeks for any possible side effects or whether they develop antibodies.
Harel said he is very proud to be part of such an important national mission and said he is not nervous.
If the first phase is successful, the second phase is scheduled for December and will include nearly 1,000 volunteers. A final phase will be open to 30,000 volunteers and will begin in April 2021.Segev Harel at Sheba Medical Center in Tel Aviv.Israel's Ministry of Defense
Israeli Prime Minister Benjamin Netanyahu and Defense Minister Benny Gantz visited the Sheba Medical Center in Tel Aviv, where the first vaccine was administered.
“There is a cause for a measure of cautious optimism today,” Gantz said. “Optimism, because I think excellent work is being done by our top scientists across the board, all of whom are giving their very best and this is cause for optimism.”
He said it will take time to track and process the data and draw conclusions. He asked for patience.
“I see the light at the end of the tunnel,” Netanyahu said. “I see the vaccines in the state of Israel. In this means or another, a vaccine developed here or abroad we will bring enough vaccines to the Israeli citizens and we will break free from this pandemic.”
The commercial name of the vaccine is “BriLife.” The first part of the name, “Bri”, refers to the Hebrew word for health, “briut,” the second part, “il” alludes to Israel and “life” speaks to the importance of the vaccine.
According to the Israel Institute for Biological Research, large-scale production of the vaccine has been implemented. To date, the institute has produced more than 25,000 vaccine doses.
“The work of all the hidden heroes in the institute and the hospitals has been poured into a little bottle which has the potential to bring a life-saving vaccine to the citizens of the state of Israel,” Dr. Shmuel Yitzhaki, head of the Biology Division at the IIBR told Fox News.
Officials said that, if all goes well, the vaccine could be ready for the general population as early as summer 2021.
Meanwhile, Israel opened elementary schools Sunday, as a second six-week nationwide lockdown comes to a gradual end.
Israel’s Health Ministry has recorded over 314,000 cases of the coronavirus and 2,541 deaths.Filed under Coronavirus , health , israel , public health , vaccines , 11/2/20
News Source: New York Post
Mike Preston: Strong rookie class, perhaps Ravens GM Eric DeCostas best, is ready to prove itself | COMMENTARY
Based on early results, Eric DeCosta might have put together his best draft since becoming Ravens general manager four years ago. The showcase begins Thursday night in the team’s preseason opener against the Tennessee Titans at M&T Bank Stadium.
The Ravens had 11 selections in April’s annual NFL draft, and it is conceivable that at least four or five end up in the starting lineup in some capacity this year, even without injuries.
That’s a pretty good haul.
In fairness, it takes about three to four years to determine the worth of a draft class, but this one has been fairly impressive so far in training camp.
DeCosta didn’t set the bar too high in his first three seasons, especially after his predecessor Ozzie Newsome had a strong walk-off performance in 2018 by trading back into the first round and selecting quarterback Lamar Jackson with the No. 32 overall pick. Offensive tackle Orlando Brown Jr. and tight end Mark Andrews, two future Pro Bowl selections, were picked in the third round that year.
Looking back now, DeCosta’s first class in 2019 was a dud, with the Ravens taking Oklahoma wide receiver Marquise Brown in the first round and then Louisiana Tech outside linebacker Jaylon Ferguson and Notre Dame wide receiver Miles Boykin in the third.
None of those picks are still with the Ravens. Brown was traded to the Arizona Cardinals on the opening day of this year’s draft for a first-round pick that became Iowa center Tyler Linderbaum, which made his selection somewhat salvageable.
Since then, the Ravens have drafted some strong players such as running back J.K. Dobbins and defensive lineman Justin Madubuike in 2020 and wide receiver Rashod Bateman and outside linebacker Odafe Oweh in 2021.
If linebacker Patrick Queen and receivers Devin Duvernay and James Proche II, all from that 2020 class, can have strong breakout seasons, then the Ravens will have a really strong young nucleus.
This current crop of rookies, including safety Kyle Hamilton (first round, Notre Dame), Linderbaum (first round, Iowa), cornerback Jalyn Armour-Davis (fourth round, Alabama) and punter Jordan Stout (fourth round, Penn State), is expected to get ample playing time.
If outside linebacker David Ojabo (second round, Michigan), recovers from a torn Achilles tendon, he’ll get on the field this season as well.
Hamilton has already been inserted into several packages. At 6 feet 4 and 220 pounds, he is athletically and physically talented. He looks the part, and while he’s been beat a few times and had about two mediocre practices late last week, he’s rebounded well.
Linderbaum has missed the last couple of practices with a foot injury but had been steady until that point. Like most linemen, he needs a strong offseason in the weight room to add muscle because there have been times when nose tackle Michael Pierce has tossed him around like a paper clip.
Armour-Davis is the prototype at cornerback. At 6-1 and 195 pounds, he is long, lean and has exceptional quickness and recovery speed. He is versatile enough to play inside or outside, so he’ll get on the field in certain substitution packages. Playing behind Pro Bowl cornerbacks Marlon Humphrey and Marcus Peters is the ideal situation for a rookie.
Stout is the punter and it is his job to lose. Even if he falters, the Ravens have a great fallback plan in former starter Sam Koch, now a special teams consultant.
Ojabo creates excitement because he is everything that Oweh wasn’t a year ago. He looks big and rugged, while Oweh came to the Ravens last season relying on speed to the outside, and little else.
Ojabo has an assortment of moves, from the swim to the arm rips to the spin, which makes him the most intriguing of all the draft picks.
Besides rookies who might help the Ravens right away, there are other players who have potential. Like Linderbaum, tight end Isaiah Likely (fourth round, Coastal Carolina) needs a year in the weight room. It will be interesting to see who gets in playing shape first, Pierce or rookie nose tackle Travis Jones (third round, Connecticut), but Jones can become a good player.
Cornerback Damarion Williams (fourth round, Houston) has shown some playmaking ability, as has running back Tyler Badie (sixth round, Missouri).
It is a new season for rookies. They made it through minicamps after the draft, the first day of contact — a big moment for those guys — and two weeks of training camp practice. Now it’s time for the preseason.
Coach John Harbaugh will hold out a lot of the Ravens’ starters, including Jackson, Andrews and Dobbins. Most of them probably won’t play until the regular-season opener against the New York Jets on Sept. 11.
So, these rookies will get a chance to play, and we’ll find out if they can make the grade in the NFL. It’s early, but so far this draft class looks like DeCosta’s most promising.